Consider these research findings: Biofilm formation: Bacterial biofilms can form in chronic nummular lesions, contributing to treatment resistance [3] Altered drug penetration: The thick, scaly (hyperkeratotic) nature of chronic lesions can reduce the absorption of topical medications [13] Neurogenic inflammation: The density of nerve fibers containing Substance P, a neuropeptide involved in inflammation and itching, is significantly increased in nummular eczema lesions [14] Most frustrating is the rebound phenomenon that can occur after discontinuing topical steroids, which can lead to a dependency cycle [15]
Shaking creates violent physical forces inside the vial that tear apart the peptide structure
Currently, it sits outside of both Category 1 and Category 2 as the FDA re-evaluates its specific compounding applications
In addition, cerebral inflammation is known to be a key component of some neurologic diseases including Alzheimers disease, multiple sclerosis, and migraine (19)
The Journal of Clinical Endocrinology and Metabolism, 96 (1), 150-158
Their safety profiles more closely resemble full GH therapy than AOD-9604s profile